- Pediatric genetics specialists Dr. Leah Burke and Dr. Mark Korson presented on genetic testing modalities and biochemical tests that can help identify underlying genetic or metabolic disorders.
- They reviewed various genetic testing options including karyotyping, FISH, microarrays, and sequencing and discussed their strengths and limitations. Variants of uncertain significance were highlighted as a challenge.
- Clinical findings that should prompt referral for further genetic evaluation were discussed. These "red flags" included individuals who are too tall/short, develop too early/late, have too many/few features, or have features that are too different.
- An initial genetics evaluation was outlined including obtaining a three generation family history, physical exam
Rare Disease Day 2017 March 30 - 31, 2017 Day 2: Genomics for Rare Diseases Dr. Anna Lehman Provincial Medical Genetics Program Adult Metabolic Diseases Clinic Department of Medical Genetics BC Children’s Hospital Research Institute
Turner syndrome is caused by complete or partial monosomy of the X chromosome in females. It is characterized by short stature, infertility, and other physical traits. The document discusses the history and genetics of Turner syndrome, including that the most common karyotype is 45,X and variants involve an isochromosome or ring chromosome. Phenotypic features can range from mild to severe and include lymphedema, heart and kidney problems, learning disabilities, and infertility. Prenatal diagnoses are now possible by ultrasound abnormalities or amniocentesis. Treatment focuses on growth hormone, estrogen therapy, and managing associated health issues.
This document provides guidance on evaluating floppy infants. It discusses the importance of assessing muscle tone and differentiating between central, peripheral, and mixed hypotonia. A thorough history and physical exam can help localize the cause and narrow the differential diagnosis, which includes various central nervous system disorders, peripheral nerve and muscle diseases, and metabolic conditions. The document outlines steps for evaluating tone, important exam findings for different etiologies, and differential diagnoses to consider in floppy infants.
Fragile X syndrome is a genetic condition caused by a mutation on the X chromosome. It results in the silencing of the FMR1 gene and inability to produce the FMRP protein required for normal neural development. Symptoms include intellectual disabilities, distinct physical features like large ears and jaw, and behaviors such as anxiety, hyperactivity and autism. While there is no cure, treatment focuses on therapies to improve speech, motor skills, and behaviors, as well as medications to manage symptoms like attention issues. It is the most common inherited form of intellectual disability.
Fragile X syndrome is a genetic disorder and the most common inherited form of intellectual disability. It is caused by a mutation on the X chromosome that results in failure to produce a protein called FMRP. Without this protein, synaptic connections in the brain are abnormal. Fragile X syndrome symptoms can include cognitive impairment, behavioral and learning challenges, and various physical characteristics. While there is no cure, treatment aims to manage symptoms through educational support, therapies, and medications. Research continues on developing targeted drug therapies to treat the underlying condition.
Millie, a 3 month old girl, was brought to the pediatrician with issues feeding, irritability, and muscle spasms. Tests found she had no GALC enzyme activity and an MRI showed demyelination. She was diagnosed with Krabbe disease, a rare inherited disorder caused by mutations in the GALC gene resulting in myelin loss and impaired nervous system development. There is currently no approved treatment, but research is exploring inhibitors of enzymes involved in the disease process.
Metachromatic leukodystrophy is a rare lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase A. This leads to a buildup of sulfatide in the body's cells. It is inherited in an autosomal recessive pattern and causes demyelination in the nervous system. Clinical presentations vary by age of onset, but common symptoms include cognitive and behavioral issues. Hematopoietic stem cell transplantation is the primary treatment option.
Rare Disease Day 2017 March 30 - 31, 2017 Day 2: Genomics for Rare Diseases Dr. Anna Lehman Provincial Medical Genetics Program Adult Metabolic Diseases Clinic Department of Medical Genetics BC Children’s Hospital Research Institute
Turner syndrome is caused by complete or partial monosomy of the X chromosome in females. It is characterized by short stature, infertility, and other physical traits. The document discusses the history and genetics of Turner syndrome, including that the most common karyotype is 45,X and variants involve an isochromosome or ring chromosome. Phenotypic features can range from mild to severe and include lymphedema, heart and kidney problems, learning disabilities, and infertility. Prenatal diagnoses are now possible by ultrasound abnormalities or amniocentesis. Treatment focuses on growth hormone, estrogen therapy, and managing associated health issues.
This document provides guidance on evaluating floppy infants. It discusses the importance of assessing muscle tone and differentiating between central, peripheral, and mixed hypotonia. A thorough history and physical exam can help localize the cause and narrow the differential diagnosis, which includes various central nervous system disorders, peripheral nerve and muscle diseases, and metabolic conditions. The document outlines steps for evaluating tone, important exam findings for different etiologies, and differential diagnoses to consider in floppy infants.
Fragile X syndrome is a genetic condition caused by a mutation on the X chromosome. It results in the silencing of the FMR1 gene and inability to produce the FMRP protein required for normal neural development. Symptoms include intellectual disabilities, distinct physical features like large ears and jaw, and behaviors such as anxiety, hyperactivity and autism. While there is no cure, treatment focuses on therapies to improve speech, motor skills, and behaviors, as well as medications to manage symptoms like attention issues. It is the most common inherited form of intellectual disability.
Fragile X syndrome is a genetic disorder and the most common inherited form of intellectual disability. It is caused by a mutation on the X chromosome that results in failure to produce a protein called FMRP. Without this protein, synaptic connections in the brain are abnormal. Fragile X syndrome symptoms can include cognitive impairment, behavioral and learning challenges, and various physical characteristics. While there is no cure, treatment aims to manage symptoms through educational support, therapies, and medications. Research continues on developing targeted drug therapies to treat the underlying condition.
Millie, a 3 month old girl, was brought to the pediatrician with issues feeding, irritability, and muscle spasms. Tests found she had no GALC enzyme activity and an MRI showed demyelination. She was diagnosed with Krabbe disease, a rare inherited disorder caused by mutations in the GALC gene resulting in myelin loss and impaired nervous system development. There is currently no approved treatment, but research is exploring inhibitors of enzymes involved in the disease process.
Metachromatic leukodystrophy is a rare lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase A. This leads to a buildup of sulfatide in the body's cells. It is inherited in an autosomal recessive pattern and causes demyelination in the nervous system. Clinical presentations vary by age of onset, but common symptoms include cognitive and behavioral issues. Hematopoietic stem cell transplantation is the primary treatment option.
1. Duchenne muscular dystrophy is an X-linked recessive genetic disorder that causes progressive muscle weakness in boys. It is characterized by muscle degeneration and affects 1 in 3,600 male births.
2. Genetic counseling for DMD involves 5 steps - reaching a diagnosis through family history, examinations, and tests; assessing recurrence risks; communicating the condition; discussing options; and providing long-term support.
3. Prenatal diagnosis methods like amniocentesis and ultrasound can determine if a male fetus is affected to allow couples to prepare or consider alternatives like abortion or adoption.
Landau-Kleffner syndrome (LKS) is a rare childhood epilepsy syndrome characterized by the gradual loss of language skills and the development of seizures. A 12-year-old girl presented with a gradual loss of speech and language at age 7 and was later diagnosed with LKS. Her symptoms included seizures, attention issues, and language regression. Testing found continuous spike-wave discharges during sleep on EEG. She was treated with medications, IVIG, and steroids, which stabilized her seizures and improved her language skills. LKS is typically treated with anti-seizure medications, steroids, IVIG, and speech therapy, with the prognosis generally being best when symptoms start after age 6.
Genes play a significant role in determining risk of developing type 2 diabetes. Having one or both parents with the condition increases risk by 15-75%, while identical twins show a 90% concordance rate. Several genes have been identified that may contribute to diabetes through effects on insulin secretion, action, fat metabolism and storage. However, environmental factors like diet and lifestyle are also important, as adoption of a Western lifestyle can increase risk even in populations that were previously low-risk. Both genes and environment interact to promote conditions like insulin resistance through their combined effects on cells and metabolism.
Tay-Sachs disease is a rare genetic disorder that causes fatty substances to build up in brain cells, leading to nerve cell damage and death. There are three main types - Classic Infantile, Juvenile, and Late Onset. Classic Infantile symptoms usually appear around 6 months of age and include slowed development and loss of skills. Juvenile symptoms begin in childhood and include slurred speech and muscle weakness. Late Onset symptoms may first appear in childhood or adulthood and include weakness and mental/mobility decline. Tay-Sachs is diagnosed through a blood or genetic test and managed through symptom relief but has no cure.
Pediatrics. trisomy 21. Meiotic non-disjunction of chromosome 21. clinical features and associated abnormalities of down syndrome. screening test for down syndrome. counseling for parents in down syndrome.
Angelman syndrome is a genetic disorder. It causes delayed development, problems with speech and balance, intellectual disability, and sometimes, seizures. People with Angelman syndrome often smile and laugh frequently, and have happy, excitable personalities.
This document discusses genetics in neurological disorders and the role of genetic counseling. It begins by introducing how neurogenetic diseases are common and devastating, robbing individuals of quality of life. The majority of neurological disorders still lack effective therapies. Genetics play an important role in many neurological disorders, including chromosomal abnormalities, Mendelian disorders caused by single gene mutations, and complex disorders involving multiple genetic and environmental factors. Patterns of inheritance such as autosomal dominant, autosomal recessive, X-linked, and mitochondrial are described. The importance of family history, clues to genetic causes, and assessing sporadic cases are outlined. The roles and aspects of genetic counseling are defined, including diagnosis, education, testing options, treatment options,
This document discusses the increasing use of genetics in clinical medicine. It covers topics like germline alterations, genetic susceptibility to common diseases, the role of primary care physicians in genetics, and advances in genetic testing techniques. The importance of understanding a patient's family history and genetic risks is emphasized. Different patterns of genetic inheritance for various conditions are reviewed, along with examples of monogenic disorders and cancer syndromes. Emerging areas like pharmacogenomics and personalized medicine are also mentioned.
This presentation is fetures the basic introduction to Genome mosaicism in humans and nature, with some examples of its harmful effects on humans, with
Fanconi anemia is a rare genetic disorder that affects DNA repair and increases cancer risk. It is caused by mutations in one of several genes involved in the FA DNA repair pathway. Symptoms include bone marrow failure, physical abnormalities, and blood cancers. While there is no cure, treatment focuses on managing symptoms and complications through blood transfusions, antibiotics, bone marrow transplants, and cancer therapies.
This document provides guidance on evaluating and diagnosing the cause of hypotonia or floppiness in infants. It outlines the importance of a thorough history and neurological examination to localize the lesion. The document separates causes into those involving the upper motor neuron, lower motor neuron, neuromuscular junction, or muscle. Specific clinical clues are provided to help determine if the hypotonia is accompanied by weakness and to identify patterns of weakness that may point to particular conditions. A structured approach and choice of targeted investigations is recommended based on the clinical findings. Definitive diagnosis may involve specialized tests like genetic testing, imaging, or biopsies.
Wiskott-Aldrich Syndrome is a rare X-linked immunodeficiency disease characterized by immunodeficiency, thrombocytopenia, and eczema. It is caused by mutations in the WAS protein gene which regulates actin cytoskeleton organization. This leads to defects in T-cells and B-cells, recurrent infections, bleeding issues, and increased cancer risk. The only cure is hematopoietic stem cell transplant from a matched sibling donor, while treatment focuses on antibiotics, platelet transfusions, and IVIG for antibody replacement.
1. The document discusses EEG patterns and findings in various neurological conditions seen in children. It includes descriptions of normal EEG findings as well as abnormal patterns seen in conditions like absence seizures, West syndrome, benign childhood epilepsy with centrotemporal spikes, Lennox-Gastaut syndrome, non-convulsive status epilepticus, subacute sclerosing panencephalitis, and herpes encephalitis.
2. Case studies are presented with clinical histories and EEG findings to illustrate different pathologies. Treatment options are also mentioned for many of the conditions.
3. International standards for EEG electrode placement and recording parameters are reviewed. Characteristics of different EEG waves, amplitudes, and patterns are described.
Approach to first unprovoked seizure in children uploadAzilah Sulaiman
- One of the most common neurological disorders in children is epilepsy, with over 120,000 children seeing a doctor annually for a new onset seizure. Clinical history is key to determining the likelihood of seizure recurrence after a child experiences their first afebrile seizure. There are 5 important questions to consider: 1) Was it truly an epileptic seizure? 2) What is the cause? 3) Which investigations should be done? 4) Does the child need treatment? 5) What else should be considered? Making an accurate diagnosis, identifying risk factors for recurrence, and considering treatment options on a case-by-case basis are essential in managing a child after their first seizure.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
The document discusses haemoglobin disorders and haemoglobinopathies. It provides details on the molecular basis, inheritance patterns, clinical presentation and diagnosis of conditions like thalassaemia, sickle cell disease and other haemoglobin variants. Key points include that haemoglobin disorders are globally common due to ancestral mutations, are usually inherited in an autosomal recessive pattern, and can be diagnosed through blood tests, family history and molecular genetic analysis. Screening programs have helped identify carriers and provide prenatal diagnosis services.
This document discusses several neurocutaneous syndromes including their definitions, genetics, classifications, and key details. It provides in-depth information on Neurofibromatosis types 1 and 2, Tuberous Sclerosis, Sturge-Weber Syndrome, and Von Hippel-Lindau disease. For each condition, it outlines diagnostic criteria, clinical manifestations, management approaches, and important follow-up considerations.
Multiple myeloma is characterized by neoplastic proliferation of plasma cells producing monoclonal immunoglobulin. It commonly affects elderly individuals and presents with bone disease, anemia, infections and renal failure. Diagnosis involves finding monoclonal proteins in serum or urine and plasma cell infiltration in bone marrow. Treatment aims to improve quality of life and may include chemotherapy, stem cell transplant, supportive care and management of complications.
Down syndrome is a genetic condition caused by the presence of an extra chromosome 21, either fully or partially. It causes developmental delays and cognitive impairment. The majority (95%) of Down syndrome cases are caused by trisomy 21, where there are three copies of chromosome 21 instead of the usual two. Risk increases with the age of the mother. Screening tests during pregnancy can identify 87% of cases, and diagnostic tests like amniocentesis or CVS can confirm the diagnosis. Common physical traits include a flattened face and small stature. Individuals with Down syndrome also have an increased risk of health issues like congenital heart defects, leukemia, and early-onset Alzheimer's disease.
1. The document discusses the genetics of several cognitive disorders in elderly individuals, including Alzheimer's disease, frontotemporal lobar degeneration, Lewy body disease, vascular dementia, and Huntington's disease.
2. For Alzheimer's disease, mutations in the APP, PSEN1, and PSEN2 genes are associated with early-onset familial Alzheimer's, while the APOE ε4 allele is a major genetic risk factor for late-onset Alzheimer's.
3. For frontotemporal lobar degeneration, mutations in the PGRN and MAPT genes are most common, while other genes like C9ORF72 and VCP have also been linked. Genetic causes
This document provides an overview of genetic screening, counseling, and prenatal testing. It discusses:
1) The need for genetic screening to identify individuals at risk for genetic disorders and provide reproductive options. Screening can detect disorders before symptoms appear.
2) The role of genetic counseling in gathering a family history, conducting evaluations, recognizing patterns of inheritance, and explaining diagnosis, prognosis and inheritance to patients.
3) Prenatal testing options like nuchal translucency measurement and amniocentesis that can detect chromosomal abnormalities in fetuses.
Genetic disorders occur due to problems in chromosomes or genes that cause health issues or physical abnormalities. There are several types of genetic disorders including single gene disorders, chromosomal abnormalities, and multifactorial disorders. Tests for genetic disorders include screening tests to check risk and diagnostic tests to detect disorders. Genetic counseling helps patients understand risk and testing options for disorders in their family. Treatment depends on the specific disorder but may include specialized care before and after birth. Some cancers have genetic components so testing can guide prevention and screening efforts.
1. Duchenne muscular dystrophy is an X-linked recessive genetic disorder that causes progressive muscle weakness in boys. It is characterized by muscle degeneration and affects 1 in 3,600 male births.
2. Genetic counseling for DMD involves 5 steps - reaching a diagnosis through family history, examinations, and tests; assessing recurrence risks; communicating the condition; discussing options; and providing long-term support.
3. Prenatal diagnosis methods like amniocentesis and ultrasound can determine if a male fetus is affected to allow couples to prepare or consider alternatives like abortion or adoption.
Landau-Kleffner syndrome (LKS) is a rare childhood epilepsy syndrome characterized by the gradual loss of language skills and the development of seizures. A 12-year-old girl presented with a gradual loss of speech and language at age 7 and was later diagnosed with LKS. Her symptoms included seizures, attention issues, and language regression. Testing found continuous spike-wave discharges during sleep on EEG. She was treated with medications, IVIG, and steroids, which stabilized her seizures and improved her language skills. LKS is typically treated with anti-seizure medications, steroids, IVIG, and speech therapy, with the prognosis generally being best when symptoms start after age 6.
Genes play a significant role in determining risk of developing type 2 diabetes. Having one or both parents with the condition increases risk by 15-75%, while identical twins show a 90% concordance rate. Several genes have been identified that may contribute to diabetes through effects on insulin secretion, action, fat metabolism and storage. However, environmental factors like diet and lifestyle are also important, as adoption of a Western lifestyle can increase risk even in populations that were previously low-risk. Both genes and environment interact to promote conditions like insulin resistance through their combined effects on cells and metabolism.
Tay-Sachs disease is a rare genetic disorder that causes fatty substances to build up in brain cells, leading to nerve cell damage and death. There are three main types - Classic Infantile, Juvenile, and Late Onset. Classic Infantile symptoms usually appear around 6 months of age and include slowed development and loss of skills. Juvenile symptoms begin in childhood and include slurred speech and muscle weakness. Late Onset symptoms may first appear in childhood or adulthood and include weakness and mental/mobility decline. Tay-Sachs is diagnosed through a blood or genetic test and managed through symptom relief but has no cure.
Pediatrics. trisomy 21. Meiotic non-disjunction of chromosome 21. clinical features and associated abnormalities of down syndrome. screening test for down syndrome. counseling for parents in down syndrome.
Angelman syndrome is a genetic disorder. It causes delayed development, problems with speech and balance, intellectual disability, and sometimes, seizures. People with Angelman syndrome often smile and laugh frequently, and have happy, excitable personalities.
This document discusses genetics in neurological disorders and the role of genetic counseling. It begins by introducing how neurogenetic diseases are common and devastating, robbing individuals of quality of life. The majority of neurological disorders still lack effective therapies. Genetics play an important role in many neurological disorders, including chromosomal abnormalities, Mendelian disorders caused by single gene mutations, and complex disorders involving multiple genetic and environmental factors. Patterns of inheritance such as autosomal dominant, autosomal recessive, X-linked, and mitochondrial are described. The importance of family history, clues to genetic causes, and assessing sporadic cases are outlined. The roles and aspects of genetic counseling are defined, including diagnosis, education, testing options, treatment options,
This document discusses the increasing use of genetics in clinical medicine. It covers topics like germline alterations, genetic susceptibility to common diseases, the role of primary care physicians in genetics, and advances in genetic testing techniques. The importance of understanding a patient's family history and genetic risks is emphasized. Different patterns of genetic inheritance for various conditions are reviewed, along with examples of monogenic disorders and cancer syndromes. Emerging areas like pharmacogenomics and personalized medicine are also mentioned.
This presentation is fetures the basic introduction to Genome mosaicism in humans and nature, with some examples of its harmful effects on humans, with
Fanconi anemia is a rare genetic disorder that affects DNA repair and increases cancer risk. It is caused by mutations in one of several genes involved in the FA DNA repair pathway. Symptoms include bone marrow failure, physical abnormalities, and blood cancers. While there is no cure, treatment focuses on managing symptoms and complications through blood transfusions, antibiotics, bone marrow transplants, and cancer therapies.
This document provides guidance on evaluating and diagnosing the cause of hypotonia or floppiness in infants. It outlines the importance of a thorough history and neurological examination to localize the lesion. The document separates causes into those involving the upper motor neuron, lower motor neuron, neuromuscular junction, or muscle. Specific clinical clues are provided to help determine if the hypotonia is accompanied by weakness and to identify patterns of weakness that may point to particular conditions. A structured approach and choice of targeted investigations is recommended based on the clinical findings. Definitive diagnosis may involve specialized tests like genetic testing, imaging, or biopsies.
Wiskott-Aldrich Syndrome is a rare X-linked immunodeficiency disease characterized by immunodeficiency, thrombocytopenia, and eczema. It is caused by mutations in the WAS protein gene which regulates actin cytoskeleton organization. This leads to defects in T-cells and B-cells, recurrent infections, bleeding issues, and increased cancer risk. The only cure is hematopoietic stem cell transplant from a matched sibling donor, while treatment focuses on antibiotics, platelet transfusions, and IVIG for antibody replacement.
1. The document discusses EEG patterns and findings in various neurological conditions seen in children. It includes descriptions of normal EEG findings as well as abnormal patterns seen in conditions like absence seizures, West syndrome, benign childhood epilepsy with centrotemporal spikes, Lennox-Gastaut syndrome, non-convulsive status epilepticus, subacute sclerosing panencephalitis, and herpes encephalitis.
2. Case studies are presented with clinical histories and EEG findings to illustrate different pathologies. Treatment options are also mentioned for many of the conditions.
3. International standards for EEG electrode placement and recording parameters are reviewed. Characteristics of different EEG waves, amplitudes, and patterns are described.
Approach to first unprovoked seizure in children uploadAzilah Sulaiman
- One of the most common neurological disorders in children is epilepsy, with over 120,000 children seeing a doctor annually for a new onset seizure. Clinical history is key to determining the likelihood of seizure recurrence after a child experiences their first afebrile seizure. There are 5 important questions to consider: 1) Was it truly an epileptic seizure? 2) What is the cause? 3) Which investigations should be done? 4) Does the child need treatment? 5) What else should be considered? Making an accurate diagnosis, identifying risk factors for recurrence, and considering treatment options on a case-by-case basis are essential in managing a child after their first seizure.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
The document discusses haemoglobin disorders and haemoglobinopathies. It provides details on the molecular basis, inheritance patterns, clinical presentation and diagnosis of conditions like thalassaemia, sickle cell disease and other haemoglobin variants. Key points include that haemoglobin disorders are globally common due to ancestral mutations, are usually inherited in an autosomal recessive pattern, and can be diagnosed through blood tests, family history and molecular genetic analysis. Screening programs have helped identify carriers and provide prenatal diagnosis services.
This document discusses several neurocutaneous syndromes including their definitions, genetics, classifications, and key details. It provides in-depth information on Neurofibromatosis types 1 and 2, Tuberous Sclerosis, Sturge-Weber Syndrome, and Von Hippel-Lindau disease. For each condition, it outlines diagnostic criteria, clinical manifestations, management approaches, and important follow-up considerations.
Multiple myeloma is characterized by neoplastic proliferation of plasma cells producing monoclonal immunoglobulin. It commonly affects elderly individuals and presents with bone disease, anemia, infections and renal failure. Diagnosis involves finding monoclonal proteins in serum or urine and plasma cell infiltration in bone marrow. Treatment aims to improve quality of life and may include chemotherapy, stem cell transplant, supportive care and management of complications.
Down syndrome is a genetic condition caused by the presence of an extra chromosome 21, either fully or partially. It causes developmental delays and cognitive impairment. The majority (95%) of Down syndrome cases are caused by trisomy 21, where there are three copies of chromosome 21 instead of the usual two. Risk increases with the age of the mother. Screening tests during pregnancy can identify 87% of cases, and diagnostic tests like amniocentesis or CVS can confirm the diagnosis. Common physical traits include a flattened face and small stature. Individuals with Down syndrome also have an increased risk of health issues like congenital heart defects, leukemia, and early-onset Alzheimer's disease.
1. The document discusses the genetics of several cognitive disorders in elderly individuals, including Alzheimer's disease, frontotemporal lobar degeneration, Lewy body disease, vascular dementia, and Huntington's disease.
2. For Alzheimer's disease, mutations in the APP, PSEN1, and PSEN2 genes are associated with early-onset familial Alzheimer's, while the APOE ε4 allele is a major genetic risk factor for late-onset Alzheimer's.
3. For frontotemporal lobar degeneration, mutations in the PGRN and MAPT genes are most common, while other genes like C9ORF72 and VCP have also been linked. Genetic causes
This document provides an overview of genetic screening, counseling, and prenatal testing. It discusses:
1) The need for genetic screening to identify individuals at risk for genetic disorders and provide reproductive options. Screening can detect disorders before symptoms appear.
2) The role of genetic counseling in gathering a family history, conducting evaluations, recognizing patterns of inheritance, and explaining diagnosis, prognosis and inheritance to patients.
3) Prenatal testing options like nuchal translucency measurement and amniocentesis that can detect chromosomal abnormalities in fetuses.
Genetic disorders occur due to problems in chromosomes or genes that cause health issues or physical abnormalities. There are several types of genetic disorders including single gene disorders, chromosomal abnormalities, and multifactorial disorders. Tests for genetic disorders include screening tests to check risk and diagnostic tests to detect disorders. Genetic counseling helps patients understand risk and testing options for disorders in their family. Treatment depends on the specific disorder but may include specialized care before and after birth. Some cancers have genetic components so testing can guide prevention and screening efforts.
Genetic screening counseling Prenatal Testing M Phil 17 2-15Yahya Noori, Ph.D
This document provides an overview of genetic counseling, screening, and prenatal testing. It discusses:
- The purpose of genetic screening to identify individuals at risk for genetic disorders and provide reproductive options.
- Methods of genetic counseling including gathering a family history, physical exam, and laboratory testing to establish diagnoses.
- Prenatal testing options like nuchal translucency measurement and amniocentesis to detect chromosomal abnormalities.
- Principles of genetic screening tests and the importance of follow-up diagnostic testing for positive results.
- Factors that influence genetic risk like penetrance and expressivity of traits.
- Examples of career screening programs and challenges in genetic counseling like consanguinity.
Genetic counselling provides information and advice about genetic conditions to help couples understand risks and make decisions. It aims to reduce births of genetically defective babies by educating about hereditary patterns, tests, and management options. Genetic counsellors assess family histories, explain diagnoses and recurrence risks, support decisions, and refer individuals to specialists. Nurses help obtain histories, provide psychological support, educate about conditions, and coordinate care during the counselling process.
Psyc 221 biological foundation prenatal.pptxyesasko
The document discusses biological and environmental foundations of human development. It covers several key topics in 3 sentences:
Genetic inheritance is determined by chromosomes containing DNA that is passed down from parents. Phenotypes (observable traits) are influenced by both genetic makeup and experiences over one's lifetime. Environmental factors like family socioeconomic status and community ties also shape child development outcomes.
This document provides an overview of genetic disorders including their causes, inheritance, diagnosis, and treatment. It discusses how genetic disorders occur due to mutations in genes that affect protein production. Diagnosis involves examining family histories, conducting genetic tests, and looking for characteristic physical features. Common genetic disorders like Down syndrome, Huntington's disease, and Duchenne muscular dystrophy are described. Treatment focuses on managing symptoms while prognosis depends on the specific disorder. The objectives are to help audiences understand genetic disorders, inheritance patterns, diagnosis strategies and common examples.
This document summarizes the career and accomplishments of Dr. Narendra Malhotra, an Indian obstetrician and gynecologist. It lists his positions including professor, dean, editor of journals, and representative for several medical organizations. It also lists his awards, publications, guest lectures, and roles organizing conferences. The document then summarizes four prenatal cases where chromosomal microarray analysis (CMA) provided clinically relevant genetic findings beyond what standard tests like ultrasound, karyotyping, and FISH could detect. CMA identified deletions and duplications involving disease-associated genes that helped with counseling and clinical management. The last case highlights some of the challenges in interpreting CMA results prenatally.
Genetic testing analyzes human DNA to detect genotypes, mutations, and karyotypes for clinical purposes. There are two main types - constitutional tests for inherited disorders impact patients and families by providing diagnostic and reproductive information, while acquired disease tests like cancer genetics help with diagnosis, prognosis and treatment selection. Genetic testing is increasingly relevant to many aspects of life.
In utero testing of foetus for genetic defectsPiyushPal24
A presentation on the various genetic disorders, their diagnosis and possible cure in the future along with an account on genetic counselling. This presentation is more of a review on the topic.
Investigations for iufd & sb, how to select?Wafaa Benjamin
Standard investigations for IUFD include maternal blood tests, Kleihauer test, serology for TORCH and syphilis, random blood glucose, HbA1c, and thyroid tests. Foetal and placental investigations include microbiology, karyotype, and post-mortem examination. Selective investigations may also be considered depending on clinical assessment and history, such as maternal coagulation tests if DIC is suspected, bacteriology if infection is suspected, and thrombophilia screening if placental disease is suspected. The diagnostic yield is highest with post-mortem examination of the baby and placenta, though consent is required. The cause remains unknown in about half of IUFD cases even after investigation.
This document summarizes key aspects of heredity and prenatal development. It discusses how chromosomes and genes influence traits and development. It describes genetic abnormalities like Down syndrome and sex-linked disorders. Prenatal testing methods like amniocentesis and ultrasound are outlined. Factors impacting fertility and conception chances are noted. The three stages of prenatal development - germinal, embryonic, and fetal - are briefly defined.
This document discusses genetic testing, including its definition, various types, reasons for testing, results, risks and limitations. It provides information on several genetic testing methods like newborn screening, diagnostic testing, carrier testing, prenatal testing, and preimplantation testing. The document outlines the role of nurses in ensuring informed consent, counseling, confidentiality, and addressing psychological impacts of genetic testing. In summary, the document provides a comprehensive overview of genetic testing, its various applications and the ethical considerations involved.
What you should know about genetic testing for mitochondrial disordersmitoaction
Amanda Balog, CGC, Senior Genetic Counselor, Mitochondrial and Metabolic Genetics, of GeneDx discusses: "What You Should Know About Genetic Testing for Mitochondrial Disorders."
This document discusses genetic development from conception through the prenatal period in 3 main sections:
1. It describes the basic components of DNA, chromosomes, genes and how genetic material is inherited from parents during conception.
2. It explains genetic variations that occur naturally between individuals as well as commonalities, including an overview of twin types.
3. It outlines the 3 main periods of prenatal development from the zygote stage through implantation and the establishment of basic body structures in the embryonic period.
This document provides an overview of stillbirths including definitions, epidemiology, etiology, approaches to management of stillbirth cases and subsequent pregnancies. It notes that the stillbirth rate in India in 2021 was 12.4 per 1000 births. Investigating the causes of stillbirth involves examining the mother, fetus, placenta and membranes through history, examinations, tests and potentially an autopsy. Managing subsequent pregnancies after a stillbirth includes increased surveillance and optimizing any medical conditions to reduce recurrence risks. The aim is to reduce India's stillbirth rate to 10 per 1000 births by 2030.
This document provides information about genetics and genetic disorders. It defines key genetic concepts like genes, chromosomes, DNA, heredity, and genetic disorders. It then gives examples of several common genetic disorders: cystic fibrosis, sickle cell anemia, hemophilia, muscular dystrophy, Huntington's disease, and Down syndrome. For each disorder it briefly explains the genetic cause, common symptoms, and impact on those affected. The document aims to educate about basic genetics and examples of genetic conditions.
1. Ambiguous genitalia can be complicated to evaluate and manage, requiring a multidisciplinary approach.
2. The initial assessment involves determining the need for investigation, ruling out life-threatening conditions like congenital adrenal hyperplasia, and assessing the history, examination, and basic lab tests to determine the underlying cause.
3. Further investigation may include karyotyping, genetic testing, imaging, and hormone level analysis to classify the condition, locate gonads, and assess gonadal and adrenal function.
This document outlines various factors that can impact embryo implantation and cause implantation failure, including embryo quality issues, endometrial issues, and other uterine factors. It discusses grading of embryos and the implantation process. Common causes of implantation failure are discussed such as poor embryo quality due to sperm or egg issues, endometrial problems, uterine issues like fibroids, and endocrine or immune disorders. Investigations for implantation failure and methods for improving embryo quality and the endometrium are also outlined. The role of diagnostic hysteroscopy in evaluating and treating intrauterine abnormalities prior to IVF is examined along with evidence for treatments of specific issues like polyps, fibroids, septa, synechia, and hydros
Genetic screening involves testing samples of blood, tissue or fluid to check for genetic conditions or risks of transmitting genetic disorders. It can confirm suspected genetic disorders, help determine risk of developing or passing on disorders, and guide healthcare decisions. Common screening tests examine chromosomes from amniotic fluid or placental tissue, measure markers in maternal serum, or check for physical abnormalities via ultrasound. Screening helps manage pregnancies and plan for newborn health issues.
The COVID-19 pandemic has created several challenges for our country’s health care infrastructure, and the community health center workforce is no exception. Join us as we describe strategies to get patients back into dental care. Along with these strategies, participants will learn how to recognize challenges in dental practices, as well as how to engage the interdisciplinary care team through role redesign and integration to increase access to comprehensive care.
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...CHC Connecticut
In order for health centers to provide compassionate and respectful HIV prevention, care, and treatment in comprehensive primary care settings, the clinical workforce must be knowledgeable, confident, and competent in their ability to do so.
We’ll explore the need to integrate HIV care into training and education for the clinical care team, as well as educational models to train the next generation. Using Community Health Center Inc.’s Center for Key Populations Fellowship for Nurse Practitioners (NPs) as a framework for best practices, experts will discuss how to implement specialty care for key populations in your training programs. Additionally, participants will gain awareness of the importance of training the clinical workforce on key population competencies in HIV programs (e.g. HCV, MOUD, LGBTQI+ health, homelessness, and harm reduction).
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...CHC Connecticut
Improve educational training experiences at your health center by assessing your capacity and infrastructure to host health professions students.
Join the upcoming hands-on interactive activity session to learn how to utilize the Readiness to Train Assessment Tool (RTAT™). This tool was developed by HRSA-funded National Training and Technical Assistance Partners (NTTAP) at Community Health Center, Inc. (CHC) to understand organizational readiness to host health professions student training programs.
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...CHC Connecticut
The COVID-19 pandemic has resulted in significant shifts in the mode of care from face-to-face to virtual interactions. Join us as we discuss the challenges currently facing behavioral health care and at least one strategy for each. Along with these strategies, panelists will go over what integrated behavioral health care was and is before and following COVID-19, as well as what actions should be taken going forward to increase access to comprehensive care.
Panelists:
• Dr. Tim Kearney, PhD, Chief Behavioral Health Officer, Community Health Center, Inc.
• Melinda Gladden, LCSW, PMHC, Behavioral Health Clinician, Community Health Center, Inc.
• Jodi Anderson, LMFT, Virtual Telehealth Group Coordinator, Community Health Center, Inc.
Newborn screening involves testing newborns for treatable genetic and metabolic disorders through methods like dried bloodspot testing, hearing screening, and pulse oximetry. The goals are to identify at-risk newborns early before symptoms present, when treatment is most effective. Abnormal screening results require follow up diagnostic testing, education of families, and treatment if a condition is confirmed. Future directions may include expanded screening panels and genomic newborn screening, though these raise additional complex issues to consider.
Health Professions Student Training Webinar: Assessing Organizational CapacityCHC Connecticut
This document provides information about a webinar on assessing organizational capacity for health professions student training. It includes details about continuing education credits, speakers, objectives, and an overview of key aspects of assessing capacity. These include identifying willing and available faculty members, maintaining a spreadsheet of available preceptors, conducting a secondary review of space, training, and onboarding needs, and negotiating placements with academic affiliations. It also discusses best practices for clinical observation and feedback forms, and introduces some preceptor panelists. Finally, it provides an overview of the Readiness to Train Assessment Tool (RTAT) and how it can be used to understand an organization's capacity based on survey results.
Training the Next Generation: Investing in Workforce TrainingCHC Connecticut
This document provides information about an upcoming webinar on workforce training. The webinar will discuss why health centers should invest in health professions education and training programs, how to assess organizational readiness to implement such programs, and best practices for developing replicable training models. Attendees will learn how workforce development planning makes business sense by reducing costs from employee turnover and increasing access to care. A tool called the Readiness to Train Assessment can help organizations evaluate their capacity and motivation to engage in training programs. Successful training requires identifying qualified preceptors and building a culture of learning in the organization.
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...CHC Connecticut
Join us for a webinar on quality improvement in team-based care!
Building a quality improvement (QI) infrastructure within team-based care is an organizational strategy that will establish a culture of continuous improvement across departments and improve quality in all domains of performance.
Participants will learn about:
• QI infrastructure
• Facilitating QI committees
• Coach training within health centers
Faculty will also provide an example of how trained coaches use QI tools to test and implement changes within an organization.
Addressing Genetics Workforce Shortage - April 11, 2023CHC Connecticut
The document discusses the shortage of geneticists and genetic counselors in the United States. It notes that there are currently only around 1,240 medical geneticists and 4,700 genetic counselors serving the population, below the recommended levels. Many states have fewer than the recommended number of geneticists per population. The document explores ways primary care physicians can help address gaps, such as playing a more active role in selected genetic situations like cancer risk assessment. It also identifies growing the educational opportunities in genetics as important for increasing the workforce.
Implementation of Timely and Effective Transitional Care Management ProcessesCHC Connecticut
Join us to discuss best practices for integrating daily follow-ups for patients recently hospitalized for health emergencies. Effectively following up with patients is a critical responsibility for integrated care teams.
Experts will share how their teams respond to patients to identify care gaps and support the transition of care. Workflow descriptions will provide participants with the tools to support their work to adapt specific steps into their model of team-based care.
Panelists:
• Mary Blankson, DNP, APRN, FNP-C, FAAN, Chief Nursing Officer, Community Health Center, Inc.
• Veena Channamsetty, MD, FAAFP, Chief Medical Officer, Community Health Center, Inc.
• Bibian Ladino-Davis, Behavioral Health Coordinator, Weitzman Institute
Direct to Consumer Test and Ancestry Testing - March 14, 2023CHC Connecticut
Direct to Consumer Genetic and Ancestry Testing
This document discusses direct-to-consumer (DTC) genetic and ancestry testing. It defines DTC testing as testing that can be ordered by consumers without a health care provider. The document outlines the types of information provided by DTC tests, including ancestry, traits, disease risks, and results for some Mendelian conditions. However, it notes limitations like low predictive value without family history and risks of false positives. It provides examples of patients impacted by DTC testing results and emphasizes the need for confirmation of pathogenic variants by clinical genetics. The document also discusses privacy and legal issues related to DTC testing.
Implement Behavioral Health Training Programs to Address a Crucial National S...CHC Connecticut
Health centers are uniquely positioned to address the unprecedented need for behavioral health services but are challenged by the workforce shortage. Participants will gain the knowledge needed to begin conceptualization of a training pathway.
Join us to discuss the considerations of sponsoring an in-house training program across all educational levels, including the benefits, program structure, design, curriculum, supervisors' role, and required resources.
Experts will provide participants with examples from practicum and postdoctoral level training programs to help them gain confidence in developing a behavioral health training pathway.
Genetic Connections to Breast Cancer - February 14, 2023CHC Connecticut
This document discusses genetic connections to breast cancer. It begins by outlining the learning objectives, which are to understand the importance of collaboration between genetics and non-genetics experts for hereditary breast cancer patients, emphasize obtaining accurate family histories, and discuss benefits and limitations of next generation sequencing panel tests. It then discusses genetic counselors' role in oncology, hereditary cancer risks and patterns, BRCA genes, obtaining family histories, genetic testing options like multi-gene panels, interpreting results, cancer screening recommendations, and prophylactic surgery options. Resources and established risk models are also referenced.
Connective Tissue Disorders Slides - January 17, 2023CHC Connecticut
This document discusses several genetic connective tissue disorders including Ehlers Danlos syndromes, Marfan syndrome, Loeys-Dietz syndrome, Stickler syndrome, Shprintzen Goldberg syndrome, Cutis Laxa, and Osteogenesis Imperfecta. It highlights the importance of identifying these disorders to allow for timely detection of serious complications and management by multiple medical specialists. Connective tissues are the most abundant tissues in the body and connect, support, bind or separate other tissues. Identification of a connective tissue disorder through genetic diagnosis guides appropriate care.
Implementation of Facial Recognition Software for Clinical Genetics Practice...CHC Connecticut
This document discusses the potential uses of facial recognition software in clinical genetics practice and education. It provides 3 examples of how facial recognition software could help in rare disease identification and interpreting genetic testing results. The document also outlines learning objectives about identifying medical uses of facial recognition, using facial grids to match patterns to syndromes, and the importance of diverse training data.
HIV Prevention: Combating PrEP Implementation ChallengesCHC Connecticut
Expert faculty present case-based scenarios illustrating common challenges to integrating HIV PrEP in primary care. As part of improving clinical workforce development, this session will delve into a variety of specific PrEP implementation challenges. Participants will leave with strategies to overcome these obstacles to establish or strengthen their PrEP program.
Panelists:
• Marwan Haddad, MD, MPH, AAHIVS, Medical Director, Center for Key Populations, Community Health Center, Inc.,
• Jeannie McIntosh, APRN, FNP-C, AAHIVS, Family Nurse Practitioner, Center for Key Populations, Community Health Center, Inc.
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...CHC Connecticut
Join us as expert faculty outline the differences between case management, care coordination and complex care management to frame up a discussion on strategies to leverage effective models for both in-person and remote services.
Expert faculty will discuss the role of the medical assistant and the nurse in care management, as well as how standing orders and delegated orders support this work. This session will discuss how telehealth and remote patient monitoring enhancements can support complex care management for patients with chronic conditions.
Participants will leave this session with the knowledge and tools to begin or enhance implementation of chronic care management by enhancing the role of the medical assistant, nurse and the technology that supports the clinical care.
Panelists:
• Mary Blankson, DNP, APRN, FNP-C, Chief Nursing Officer, Community Health Center, Inc.
• Tierney Giannotti, MPA, Senior Program Manager, Population Health, Community Health Center Inc.
Genetics Cases and Resources Webinar Slides - November 8, 2022CHC Connecticut
The document discusses various metabolic diseases, including those that cause muscle symptoms like long chain hydroxyacyl CoA dehydrogenase (LCHAD) deficiency and Pompe disease. It provides information on fatty acid oxidation defects, describing how the body metabolizes fatty acids and the consequences of defects in breaking down different chain length fatty acids. Symptoms of long chain fatty acid oxidation defects are discussed, including fasting intolerance, encephalopathy, liver dysfunction, and muscle involvement. The diagnosis and treatment of these conditions is also summarized.
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...CHC Connecticut
This document discusses a webinar presented by Community Health Center, Inc. on their postgraduate nurse practitioner and physician assistant residency and fellowship programs. It provides an agenda for the webinar which will discuss the key program staff and their responsibilities, including the program director, clinical director, preceptors, mentors and other faculty. The webinar objectives are to identify drivers for implementing such programs, describe the implementation process, discuss program structure and highlight the roles of program staff.
Training the Next Generation within Primary CareCHC Connecticut
This document summarizes a presentation about training the next generation within primary care. It discusses Community Health Center Inc.'s various workforce development programs, including clinical and non-clinical fellowships and student programs. Specifically, it focuses on administrative fellowships, outlining their purpose and key factors to consider when establishing one, such as the fellow's access and experiences. It also describes other opportunities at the Weitzman Institute for training students, such as research programs with Wesleyan University and health policy fellowships. The presentation emphasizes that community health centers are important training grounds and considers how to structure diverse programs to support succession planning.
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTblessyjannu21
Prepared by Prof. BLESSY THOMAS, VICE PRINCIPAL, FNCON, SPN.
Emphysema is a disease condition of respiratory system.
Emphysema is an abnormal permanent enlargement of the air spaces distal to terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
Emphysema of lung is defined as hyper inflation of the lung ais spaces due to obstruction of non respiratory bronchioles as due to loss of elasticity of alveoli.
It is a type of chronic obstructive
pulmonary disease.
It is a progressive disease of lungs.
Simple Steps to Make Her Choose You Every DayLucas Smith
Simple Steps to Make Her Choose You Every Day" and unlock the secrets to building a strong, lasting relationship. This comprehensive guide takes you on a journey to self-improvement, enhancing your communication and emotional skills, ensuring that your partner chooses you without hesitation. Forget about complications and start applying easy, straightforward steps that make her see you as the ideal person she can't live without. Gain the key to her heart and enjoy a relationship filled with love and mutual respect. This isn't just a book; it's an investment in your happiness and the happiness of your partner
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
Dr. Sherman Lai, MD — Guelph's Dedicated Medical ProfessionalSherman Lai Guelph
Guelph native Dr. Sherman Lai, MD, is a committed medical practitioner renowned for his thorough medical knowledge and caring patient care. Dr. Lai guarantees that every patient receives the best possible medical care and assistance that is customized to meet their specific needs. She has years of experience and is dedicated to providing individualized health solutions.
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
Basics of Electrocardiogram
CONTENTS
●Conduction System of the Heart
●What is ECG or EKG?
●ECG Leads
●Normal waves of ECG.
●Dimensions of ECG.
● Abnormalities of ECG
CONDUCTION SYSTEM OF THE HEART
ECG:
●ECG is a graphic record of the electrical activity of the heart.
●Electrical activity precedes the mechanical activity of the heart.
●Electrical activity has two phases:
Depolarization- contraction of muscle
Repolarization- relaxation of muscle
ECG Leads:
●6 Chest leads
●6 Limb leads
1. Bipolar Limb Leads:
Lead 1- Between right arm(-ve) and left arm(+ve)
Lead 2- Between right arm(-ve) and left leg(+ve)
Lead 3- Between left arm(-ve)
and left leg(+ve)
2. Augmented unipolar Limb Leads:
AvR- Right arm
AvL- Left arm
AvF- Left leg
3.Chest Leads:
V1 : Over 4th intercostal
space near right sternal margin
V2: Over 4th intercostal space near left sternal margin
V3:In between V2 and V4
V4:Over left 5th intercostal space on the mid
clavicular line
V5:Over left 5th intercostal space on the anterior
axillary line
V6:Over left 5th intercostal space on the mid
axillary line.
Normal ECG:
Waves of ECG:
P Wave
•P Wave is a positive wave and the first wave in ECG.
•It is also called as atrial complex.
Cause: Atrial depolarisation
Duration: 0.1 sec
QRS Complex:
•QRS’ complex is also called the initial ventricular complex.
•‘Q’ wave is a small negative wave. It is continued as the tall ‘R’ wave, which is a positive wave.
‘R’ wave is followed by a small negative wave, the ‘S’ wave.
Cause:Ventricular depolarization and atrial repolarization
Duration: 0.08- 0.10 sec
T Wave:
•‘T’ wave is the final ventricular complex and is a positive wave.
Cause:Ventricular repolarization Duration: 0.2 sec
Intervals and Segments of ECG:
P-R Interval:
•‘P-R’ interval is the interval
between the onset of ‘P’wave and onset of ‘Q’ wave.
•‘P-R’ interval cause atrial depolarization and conduction of impulses through AV node.
Duration:0.18 (0.12 to 0.2) sec
Q-T Interval:
•‘Q-T’ interval is the interval between the onset of ‘Q’
wave and the end of ‘T’ wave.
•‘Q-T’ interval indicates the ventricular depolarization
and ventricular repolarization,
i.e. it signifies the
electrical activity in ventricles.
Duration:0.4-0.42sec
S-T Segment:
•‘S-T’ segment is the time interval between the end of ‘S’ wave and the onset of ‘T’ wave.
Duration: 0.08 sec
R-R Interval:
•‘R-R’ interval is the time interval between two consecutive ‘R’ waves.
•It signifies the duration of one cardiac cycle.
Duration: 0.8 sec
Dimension of ECG:
How to find heart rhytm of the heart?
Regular rhytm:
Irregular rhytm:
More than or less than 4
How to find heart rate using ECG?
If heart Rhytm is Regular :
Heart rate =
300/No.of large b/w 2 QRS complex
= 300/4
=75 beats/mins
How to find heart rate using ECG?
If heart Rhytm is irregular:
Heart rate = 10×No.of QRS complex in 6 sec 5large box = 1sec
5×6=30
10×7 = 70 Beats/min
Abnormalities of ECG:
Cardiac Arrythmias:
1.Tachycardia
Heart Rate more than 100 beats/min
1. Pediatric Genetics and
Genomics
April 28, 2020
Lab Testing and Genetic &
Metabolic Disease: Spotting
the "Red Flags"
1
Leah Burke, MD
University of Vermont
Mark Korson, MD
VMP Genetics, LLC
2. Get the Most Out of Your Experience
Use the Q&A Button to submit questions
during today’s session
Recording and slides will be sent by email
For further information, contact
WeitzmanLearning@chc1.com
2
3. Founding year: 1972
Hubs/Locations: 15/210
Patients per year: 100,000
The Weitzman Institute is a program of
3
4. 4
The Weitzman Instituteworks to improve primary care and its delivery to medically
underserved and special populationsthrough research, innovation, and the education and
training of health professionals.
4Genetics | 2/18/204
5. New England Regional Genetics
Network
The NERGN project is supported by the Health Resources and
Services Administration (HRSA) of the U.S. Department of Health
and Human Services (HHS) under grant number UH7MC30778;
New England Regional Genetics Network; total award amount:
1.5 million; 100% from governmental sources. This information
or content and conclusions are those of the author and should
not be construed as the official position or policy of, nor should
any endorsements be inferred by HRSA, HHS or the U.S.
Government.
5
6. CME Credits Available
CME credits available to live webinar
participants only
A brief survey will be sent after this session to
those who registered and attended this webinar
CME certificate will be sent to participants who
complete the survey
American Academy
Family Physicians
(AAFP)
6
9. Goals
• Review the genetic and genomic testing modalities
• Identify the clinical and family history findings that raise a
concern for a genetic disorder
• Review how simple biochemical tests that can determine
the competence of human metabolism
• Describe a few findings on routine biochemical testing that
can increase suspicion about an underlying metabolic
disease
10. Genetic Testing:
Screening vs. Diagnostic
• Testing done on a particular
population
• Individuals are asymptomatic
• Not designed to diagnose, simply
to identify individuals at a higher
risk
• May lead to diagnostic tests
• Testing done on individuals
• Individuals often symptomatic
• Individuals may have had a
positive screening test
• May lead to treatment options
18. What’s in a name?
A test by any other name…
• Microarray
• Chromosomal microarray
• Whole genome microarray
• Comparative Genomic Hybridization (CGH)
• Array CGH
Function is to determine copy number variants
20. 20
Karyotype Individual
FISH test
Microarray
Can detect whole
chromosome
differences,
translocations, and
large deletions or
duplications
Only looks at
specific areas for
deletions or
duplications
Can detect very
small duplications
or deletions
23. • A massively parallel sequencing technology in which
millions of overlapping “reads” of DNA sequences are
done simultaneously
• Creates an enormous amount of data to be analyzed
• Can detect single gene mutations including nonsense,
missense, splice-site, and frame-shift mutations
23
Next Generation Sequencing
26. Whole Exome Sequencing (WES)
• Now being offered clinically
• Parallel sequencing of at least 98% of
the coding sequences
Whole Genome Sequencing (WGS)
• Parallel sequencing of the coding and
non-coding sequences
• Some conditions are caused by DNA
changes outside the “gene”
26
Both are being considered in rapid testing
of sick newborns in the NICU and other places
29. • With whole genome sequencing or whole exome
sequencing, the chance of VUS is even greater than with
microarray testing
• The reading of the variants can be different between
different labs and over time
29
Variants of Uncertain Significance:
The Dreaded VUS
30. So when should you refer for a
genetics/metabolism evaluation?
30
31. REMEMBER THE RULE OF “TWO/TOO” (when asking questions)
• TOO tall
• TOO short
• TOO early
• TOO many
• TOO young
• TOO different
• TWO tumors
• TWO generations
• TWO in the family
• TWO birth defects
32. Let’s start with the Too’s
• TOO tall
• TOO short
• TOO early
• TOO many
• TOO young
• TOO different
32
39. Marfan Syndrome
• Tall stature with long
bone overgrowth
• Long narrow face
• High-arched palate
• Subluxation of lenses
• Spontaneous
pneumothoraces
• Arachnodactyly
• Aortic root dilation and
dissection
• Mitral regurgitation
• Scoliosis
• Pectus deformities
• Joint hypermobility
• Striae dystrophica
• Recurrent hernias
Usually due to a FBN1 (fibrillin 1) mutation
Also consider TGFBR1 and TGFBR2
40.
41. Beckwith-Wiedemann
• LGA babies without maternal diabetes
• Macroglossia
• Hemi-hypertrophy
• Ear creases and or posterior pits
• Umbilical hernia or omphalocele
• Wilms tumor
42. Too short
• History of Growth deficiency
– Onset
• Prenatal – intrauterine growth retardation
• Postnatal
– Growth maturation
• Normal
• Delayed
– Proportional
• Proportions are normal
• Malproportion
43.
44.
45. Achondroplasia
• Short-limb dwarfism –
rhizomelic shortening
• Macrocephaly with frontal
bossing
• Midface hypoplasia
• Foramen magnum
stenosis
• Upper airway obstruction
• Kyphosis and lumbar
lordosis
• Trident hand
• Limited elbow extension
• Generalized joint hypermobility
• Bowing of legs
• Conductive hearing loss
• Delayed motor development
• Occasional hydrocephalus
• Mutations in FGFR3 gene (80%
de novo)
52. Initial Genetics Evaluation: First Tier
• Three generation family history
• Medical history for clues about
birth/environmental causes
• Physical evaluation for signs of underlying
syndromes
– Targeted testing for a specific syndrome
– Metabolic and/or mitochondrial testing if indicated
• Chromosomal microarray
• Fragile X DNA testing
53. Fragile X physical features
• Macrocephaly
• Long face with
prominent jaw
and long ears
• Joint
hypermobility
• May not have any
striking features
54. Fragile X Syndrome
• Caused by a change in the FMR1 gene located
on the X chromosome
• A full mutation is expressed in 100% of males
and 50% of females
• Intellectual disability is a major feature in
affected males
• Must be tested for with a specific test that
determines the repeat size
55. Initial Genetics Evaluation: First Tier
• Three generation family history
• Medical history for clues about
birth/environmental causes
• Physical evaluation for signs of underlying
syndromes
– Targeted testing for a specific syndrome
– Metabolic and/or mitochondrial testing if indicated
• Chromosomal microarray
• Fragile X DNA testing
56. Chromosomal Microarray
An important part of the First Tier
• Numerous pathogenic copy number variants
(CNVs) have been identified in the etiology of
autism
• Yield is thought to be about 10%
• Several “hot spots” or recurrent CNVs have been
identified
• Often present in unaffected parents – variable
penetrance
57. Case
• 18 month old girl referred to genetics for gross motor delays
• Additional features
– Small VSD
– Epicanthal folds and puffy eyelids
– Upturned nose and wide mouth
– Difficulty gaining weight
• Facial features reminiscent of Williams syndrome but didn’t
completely fit
• Did the first tier of testing
57
58. Case
• Seen again at 5 ½ years and proposed doing exome sequencing
• Received approval from insurance, but parents decided to wait
• At 6 years of age, she was diagnosed with celiac disease
• Parents proceeded with testing
• A pathogenic variant was found in SETD5
58
59. SETD5
• Associated with an autosomal dominant neurodevelopmental
syndrome
• Found on the short arm of chromosome 3
• Deletions in this area have been known to cause a
neurodevelopmental syndrome
59
61. REMEMBER THE RULE OF “TWO/TOO” (when asking questions)
• TOO tall
• TOO short
• TOO early
• TOO many
• TOO young
• TOO different
• TWO tumors
• TWO generations
• TWO in the family
• TWO birth defects
63. • Chief complaint
• Family History, if available:
– Include 3 generations if available
– Designate how each person is related
– Include developmental history
– Do not limit to symptoms found in patient
– Include causes of death, esp. in early deaths
– Include miscarriages & early infant deaths
– Include consanguinity and ethnicity
WHAT THE PCP SHOULD PROVIDE WITH THE REFERRAL
64. (35)
Breast Cancer @ 63
died @ 67 - heart
disease
Breast Cancer @ 58 post-menopausal
died at 63 - metastases
Breast cancer @ 80
died @ 83
Irish, English, ScottishIrish, German
(60)
(87)
(62)
Prostate cancer 70’s (84)
(62)
66. • SC – some concerns re: diseases in family
“Do you have any questions about diseases or conditions that run in your family?”
• R – reproduction problems
“Have there been any problems with pregnancy, infertility, or birth defects in your
family?”
• E – early disease, death, or disability
“Have any members of your family become sick or died at an early age?”
• E – ethnicity
“How would you describe your ancestry?” OR “What countries do your families
originate from?
• N – non-genetic factors
“Are there any other nonmedical conditions that run in your family?”
FAMILY HISTORY SCREEN MNEMONIC
91. BLOOD GAS MEASUREMENT
pH pCO2 HCO3
Urea cycle
disorders HIGH LOW LOW
2° RESPIRATORY
ALKALOSIS 1° METABOLIC
ACIDOSIS
92. BLOOD GAS MEASUREMENT
pH pCO2 HCO3
Urea cycle
disorders HIGH LOW LOW
1° RESPIRATORY
ALKALOSIS 2° METABOLIC
ACIDOSIS
THIS SLIDE HAS BEEN UPDATED POST
PRODUCTION. THE INFORMATION ON
THIS SLIDE IS CORRECT. THE
INFORMATION ON THE SLIDE SHOWN
ON THE RECORDING IS INCORRECT AS
POINTED OUT BY DR. KORSON
93. BLOOD GAS MEASUREMENT
pH pCO2 HCO3
Organic
acidemias LOW LOW LOW
Urea cycle
disorders HIGH LOW LOW
94. A CASE OF VOMITING & LETHARGY
A 10 month old girl presents to the ER with her second
bout of vomiting and dehydration. The first resolved with
IV fluids. She is now lethargic and tachypneic. Her blood
gases show- pH=7.54, pCO2=16, HCO3=17. Electrolytes
reveal Na=142, K=3.1, Cl=107, HCO3=18. Glucose
measures 62 mg/dL.
95. QUESTION
Which ONE of the following choices regarding the
patient’s presentation is the most diagnostically helpful?
A. The glucose level
B. This is the second episode of vomiting/dehydration
C. The respiratory alkalosis
D. The metabolic acidosis
E. The patient’s lethargy
96. QUESTION
Which ONE of the following choices regarding the
patient’s presentation is the most diagnostically helpful?
A. The glucose level
B. This is the second episode of vomiting/dehydration
C. The respiratory alkalosis
D. The metabolic acidosis
E. The patient’s lethargy
98. THE ANION GAP
Difference between measured
anions and cations in the blood
Definition
Calculation Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (105 + 25)
Anion gap = 10
Normal anion gap = 10-15
99. NON-ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (115 + 10)
Anion gap = 15
Bicarbonate loss (urine or stool)
HIGH
NORMAL
LOW
100. ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (105 + 10)
Anion gap = 25
Anion accumulation
NORMAL
HIGH
LOW
115. • Aketosis or hypoketosis is always an abnormal
response to hypoglycemia (or even very prolonged
fasting)
• Exception – newborns
HYPOGLYCEMIA
116. • Routine laboratory testing can be a good indicator
for assessing basic intermediary metabolism:
• Abnormalities might suggest an underlying acute
metabolic disorder
SUMMARY
• Blood gases
• Electrolytes, bicarb (anion gap)
• Ammonia
• Glucose
• Lactate
• Urinalysis
117. WHICH IS WHICH?
Which set of lab results most likely correlates with diarrhea and
which with a metabolic
disorder?
A
CASE 1 – diarrhea
CASE 2 – metabolic disorder
B
CASE 1 – metabolic disorder
CASE 2 – diarrhea
ANALYTE CASE 1 CASE 2 NORMALS
Sodium 141 135 133–146
Potassium 5 5 3.7-5.9
Chloride 116 103 98-107
Bicarbonate 10 10 21-31
Anion gap 15 22 8-15 (without K)
118. WHICH IS WHICH?
Which set of lab results most likely correlates with diarrhea and
which with a metabolic
disorder?
A
CASE 1 – diarrhea
CASE 2 – metabolic disorder
B
CASE 1 – metabolic disorder
CASE 2 – diarrhea
ANALYTE CASE 1 CASE 2 NORMALS
Sodium 141 135 133–146
Potassium 5 5 3.7-5.9
Chloride 116 103 98-107
Bicarbonate 10 10 21-31
Anion gap 15 22 8-15 (without K)
119. NON-ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (115 + 10)
Anion gap = 15
Bicarbonate loss (urine or stool)
HIGH
NORMAL
LOW
120. ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (105 + 10)
Anion gap = 25
Anion accumulation
NORMAL
HIGH
LOW
121. THE INFANT WITH LIVER DISEASE
A 6-month old infant male, product of a healthy
pregnancy/labor/delivery, was found to have a distended
belly at 3 months. By that time, he had lost 1 kg of
weight and was failing to thrive. He continues to feed
every 3-4 hours day and night. The liver was noted to be
enlarged at 5 months of age. He was evaluated in the ED
shortly after that for fever and upper respiratory
symptoms.
122. THE INFANT WITH LIVER DISEASE
Lab tests:
• Glucose=39 mg/dL
• Mild metabolic acidosis: HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
Based on these
clinical/lab data, this
patient has liver disease.
Which other organ are
you worried about?
A. Brain
B. Kidneys
C. Distal extremities
D. Heart
E. Muscle
123. THE INFANT WITH LIVER DISEASE
Lab tests:
• Glucose=39 mg/dL
• Mild metabolic acidosis: HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
Based on these
clinical/lab data, this
patient has liver disease.
Which other organ are
you worried about?
A. Brain
B. Kidneys
C. Distal extremities
D. Heart
E. Muscle
124. May be associated with:
• Pan-liver dysfunction
• Cholestasis
• Just hepatomegaly
Often associated with renal tubular dysfunction (renal
Fanconi syndrome)
METABOLIC LIVER DISEASE
125. A CASE OF HYPOGLYCEMIA
A 2 ½ year old boy develops a cough and cold symptoms.
His PCP diagnoses a pharyngitis; the patient takes only
smaller volumes than usual. On the third day, he is pale
and difficult to rouse. He is rushed to the ED and has a
seizure in the car. His blood glucose measures 25 mg/dL.
Blood gases – pH=7.29, pCO2=31, HCO3=15. Electrolytes
measure Na=131, K=4.4, Cl=99. His urinalysis shows -
pH=5.0, no glucose or protein, and 1+ ketones.
126. QUESTION
Which ONE of the following choices regarding the
patient’s presentation is the most diagnostically helpful?
A. Hypoglycemia
B. Metabolic acidosis
C. Hypoglycemia with seizure
D. Hypoglycemia with 1+ urine ketones
E. Hypoglycemia, hyponatremia, with seizures
127. QUESTION
Which ONE of the following choices regarding the
patient’s presentation is the most diagnostically helpful?
A. Hypoglycemia
B. Metabolic acidosis
C. Hypoglycemia with seizure
D. Hypoglycemia with 1+ urine ketones
E. Hypoglycemia, hyponatremia, with seizures
133. • Aketosis or hypoketosis is always an abnormal
response to hypoglycemia (or even very prolonged
fasting)
• Exception – newborns
HYPOGLYCEMIA
134. THE CRITICALLY ILL INFANT
A male is the 5th child of non-consanguineous parents
following a normal pregnancy and delivery. Within 12
hours, he developed respiratory distress and lethargy,
requiring intubation and ventilation. Blood gases
showed: pH=7.21, pCO2=10, HCO3=4. Electrolytes:
Na=137, K=4.9, Cl=105, measured HCO3=4. Glucose=44
mg/dL. The patient was dehydrated; lactate measured 21
mmol/L (NL<2.2) but persisted despite rehydration.
Ammonia=105 μmol/L. Urinalysis: ketones=3+.
135. QUESTION
The most likely reason for the high lactic acid level in this
patient is dehydration leading to poor perfusion?
A. True
B. False
136. QUESTION
The most likely reason for the high lactic acid level in this
patient is dehydration leading to poor perfusion?
A. True
B. False
137. THE CRITICALLY ILL INFANT
A male is the 5th child of non-consanguineous parents
following a normal pregnancy and delivery. Within 12
hours, he developed respiratory distress and lethargy,
requiring intubation and ventilation. Blood gases
showed: pH=7.21, pCO2=10, HCO3=4. Electrolytes:
Na=137, K=4.9, Cl=105, measured HCO3=4. Glucose=44
mg/dL. The patient was dehydrated; lactate measured 21
mmol/L (NL<2.2) but persisted despite rehydration.
Ammonia=105 μmol/L. Urinalysis: ketones=3+.